Latest Breaking News On - Cardiff oncology company profile - Page 1 : comparemela.com

HC Wainwright Reiterates "Buy" Rating for Cardiff Oncology (NASDAQ:CRDF)

Cardiff Oncology's (CRDF) "Buy" Rating Reiterated at HC Wainwright

Cardiff Oncology (CRDF) Scheduled to Post Earnings on Thursday

Cardiff Oncology (NASDAQ:CRDF – Get Free Report) will be posting its quarterly earnings results after the market closes on Thursday, May 2nd. Analysts expect Cardiff Oncology to post earnings of ($0.25) per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link. Cardiff Oncology (NASDAQ:CRDF […]

Insider Buying: Cardiff Oncology, Inc. (NASDAQ:CRDF) Director Acquires 30,000 Shares of Stock

Cardiff Oncology, Inc. (NASDAQ:CRDF) Short Interest Down 9.4% in November

Cardiff Oncology, Inc. (NASDAQ:CRDF – Get Free Report) was the recipient of a significant decrease in short interest in November. As of November 30th, there was short interest totalling 1,450,000 shares, a decrease of 9.4% from the November 15th total of 1,600,000 shares. Based on an average daily trading volume, of 688,500 shares, the short-interest […]